{"id":13350,"date":"2024-08-23T01:02:29","date_gmt":"2024-08-22T23:02:29","guid":{"rendered":"https:\/\/valintermed.com\/?p=13350"},"modified":"2024-08-23T01:02:29","modified_gmt":"2024-08-22T23:02:29","slug":"mioma-matki","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/uterine-fibroids\/","title":{"rendered":"Uterine fibroids"},"content":{"rendered":"<div class=\"fpm_start\"><\/div>\n<p>Uterine myoma, also known as fibroma or leiomyoma, is a benign tumor that develops in the muscular layer of the uterus (myometrium). These tumors can vary in size, shape, and location, and although they often do not cause symptoms, in some cases they can lead to significant clinical manifestations. In particular, myomas can cause heavy menstrual bleeding, pelvic pain syndromes, and can also affect a woman\u2019s reproductive functions. It is important to note that although myomas are benign, in rare cases they can degenerate into malignant tumors. Understanding uterine myoma requires a comprehensive approach, including diagnosis and treatment, making this disease relevant for women of all age groups.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_83 counter-flat ez-toc-counter ez-toc-light-blue ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Content<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 eztoc-toggle-hide-by-default' ><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/uterine-fibroids\/#%D0%98%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%8F_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F_%D0%B8_%D0%B8%D0%BD%D1%82%D0%B5%D1%80%D0%B5%D1%81%D0%BD%D1%8B%D0%B5_%D0%B8%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D1%84%D0%B0%D0%BA%D1%82%D1%8B\" >History of the disease and interesting historical facts<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/uterine-fibroids\/#%D0%AD%D0%BF%D0%B8%D0%B4%D0%B5%D0%BC%D0%B8%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F\" >Epidemiology<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/uterine-fibroids\/#%D0%93%D0%B5%D0%BD%D0%B5%D1%82%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B0%D1%8F_%D0%BF%D1%80%D0%B5%D0%B4%D1%80%D0%B0%D1%81%D0%BF%D0%BE%D0%BB%D0%BE%D0%B6%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C_%D0%BA_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%BC%D1%83_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8E\" >Genetic predisposition to this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/uterine-fibroids\/#%D0%A4%D0%B0%D0%BA%D1%82%D0%BE%D1%80%D1%8B_%D1%80%D0%B8%D1%81%D0%BA%D0%B0_%D0%B2%D0%BE%D0%B7%D0%BD%D0%B8%D0%BA%D0%BD%D0%BE%D0%B2%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Risk factors for the development of this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/uterine-fibroids\/#%D0%94%D0%B8%D0%B0%D0%B3%D0%BD%D0%BE%D1%81%D1%82%D0%B8%D0%BA%D0%B0_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Diagnosis of this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/uterine-fibroids\/#%D0%9B%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D0%B5\" >Treatment<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/uterine-fibroids\/#%D0%A1%D0%BF%D0%B8%D1%81%D0%BE%D0%BA_%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2_%D0%BF%D1%80%D0%B8%D0%BC%D0%B5%D0%BD%D1%8F%D0%B5%D0%BC%D1%8B%D1%85_%D0%B4%D0%BB%D1%8F_%D0%BB%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >List of medications used to treat this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/uterine-fibroids\/#%D0%9C%D0%BE%D0%BD%D0%B8%D1%82%D0%BE%D1%80%D0%B8%D0%BD%D0%B3_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Disease monitoring<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/uterine-fibroids\/#%D0%92%D0%BE%D0%B7%D1%80%D0%B0%D1%81%D1%82%D0%BD%D1%8B%D0%B5_%D0%BE%D1%81%D0%BE%D0%B1%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D0%B8_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Age-related features of the disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/uterine-fibroids\/#%D0%92%D0%BE%D0%BF%D1%80%D0%BE%D1%81%D1%8B_%D0%B8_%D0%BE%D1%82%D0%B2%D0%B5%D1%82%D1%8B\" >Questions and Answers<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"%D0%98%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%8F_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F_%D0%B8_%D0%B8%D0%BD%D1%82%D0%B5%D1%80%D0%B5%D1%81%D0%BD%D1%8B%D0%B5_%D0%B8%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D1%84%D0%B0%D0%BA%D1%82%D1%8B\"><\/span>History of the disease and interesting historical facts<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Uterine fibroids have been known for centuries. Ancient medical treatises such as the text of Hippocrates mention various uterine diseases, although no clear diagnosis of fibroids was made. During the Middle Ages, the presence of fibroids was often associated with witchcraft and other superstitions; women suffering from this disease could be subjected to various ineffective and even dangerous treatments. In the 19th century, when the scientific direction in medicine began to develop, scientists began to study the pathological anatomy of fibroids in more depth. With the discovery of methods such as ultrasound diagnostics and hysteroscopy in the 20th century, more accurate detection and treatment of this disease became possible. Thus, uterine fibroids have come a long way in their study and diagnosis, which has greatly improved the understanding of this common condition.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%AD%D0%BF%D0%B8%D0%B4%D0%B5%D0%BC%D0%B8%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F\"><\/span>Epidemiology<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>According to current statistics, uterine fibroids are one of the most common benign tumors among women of reproductive age. It is estimated that up to 70-80% women by the age of 50 may have fibroids, but a significantly smaller percentage of them experience clinical manifestations. The prevalence of fibroids may vary depending on the geographic region, race, and ethnicity. For example, women of African descent have a higher frequency and size of fibroids compared to women of European or Asian descent. Such differences are due to both genetic factors and environmental and hormonal aspects. Another interesting feature is the age dependence: fibroids occur more often in women over 30 years of age. Thus, the epidemiology of uterine fibroids emphasizes the importance of screening and early detection of this pathology.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%93%D0%B5%D0%BD%D0%B5%D1%82%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B0%D1%8F_%D0%BF%D1%80%D0%B5%D0%B4%D1%80%D0%B0%D1%81%D0%BF%D0%BE%D0%BB%D0%BE%D0%B6%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C_%D0%BA_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%BC%D1%83_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8E\"><\/span>Genetic predisposition to this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Research shows that uterine fibroids may have a genetic predisposition. There are a number of genes associated with the development of this disease. The most studied genes include:<\/p>\n<ul>\n<li>TSEN54<\/li>\n<li>MED12<\/li>\n<li>HMGA2<\/li>\n<li>GNAS<\/li>\n<\/ul>\n<p>Mutations in these genes can lead to disruption of normal cell growth and differentiation, which in turn contributes to the formation of fibroids. For example, mutations in mediator 12 (MED12) have been identified in a significant number of fibroids, indicating its role in pathogenesis. Genetic studies have shown that women with a family history of fibroids have a significantly higher risk of developing them. Thus, genetic predisposition plays an important role in the pathogenesis of uterine fibroids and their progression.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%A4%D0%B0%D0%BA%D1%82%D0%BE%D1%80%D1%8B_%D1%80%D0%B8%D1%81%D0%BA%D0%B0_%D0%B2%D0%BE%D0%B7%D0%BD%D0%B8%D0%BA%D0%BD%D0%BE%D0%B2%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Risk factors for the development of this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>There are many risk factors associated with the development of uterine fibroids. These include:<\/p>\n<ul>\n<li>Hormonal imbalances, in particular elevated estrogen levels.<\/li>\n<li>Age: The risk increases with age, especially in women over 65 years of age.<\/li>\n<li>Overweight and obesity, which is associated with metabolic disorders.<\/li>\n<li>Heredity: presence of cases of fibroids in the family.<\/li>\n<li>Reproductive and menstrual factors such as early onset of menarche and late menopause.<\/li>\n<li>Racial predisposition, especially in women of African descent.<\/li>\n<li>Chemical factors such as exposure to certain pesticides and other toxic substances.<\/li>\n<\/ul>\n<p>These risk factors may act individually or in combination to influence the likelihood of developing fibroids. A series of studies suggest that paying attention to risk factors may help in developing programs for the prevention and early detection of fibroids in women.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%94%D0%B8%D0%B0%D0%B3%D0%BD%D0%BE%D1%81%D1%82%D0%B8%D0%BA%D0%B0_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Diagnosis of this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Diagnosis of uterine fibroids includes several stages and methods. The main symptoms that may alert the patient include:<\/p>\n<ul>\n<li>Heavy menstrual bleeding and prolonged periods.<\/li>\n<li>Pain in the pelvic area and lower abdomen.<\/li>\n<li>Problems with urination and constipation.<\/li>\n<li>Infertility or difficulties in pregnancy.<\/li>\n<\/ul>\n<p>The following laboratory and radiological studies are used to confirm the diagnosis:<\/p><script data-noptimize=\"\" data-wpfc-render=\"false\">\nfpm_start( \"true\" );\n<\/script>\n\n<ul>\n<li>Ultrasound examination (US) of the pelvic organs, which helps to visualize fibroids.<\/li>\n<li>Magnetic resonance imaging (MRI), which provides more detailed information about the size and location of tumors.<\/li>\n<li>Hysterosalpingography (HSG) to assess the condition of the uterus and identify other possible pathologies.<\/li>\n<\/ul>\n<p>Additionally, other types of diagnostics may be performed, such as hysteroscopy, a procedure that allows you to examine the inner surface of the uterus using a special endoscope. It is important to conduct a differential diagnosis to exclude other diseases, such as endometriosis and polyps, which will ensure the correct choice of therapeutic strategy.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%9B%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D0%B5\"><\/span>Treatment<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Treatment for uterine fibroids may vary depending on the symptoms, size and number of fibroids, and the patient&#039;s desire to preserve fertility. Common treatment approaches include:<\/p>\n<ul>\n<li>General treatment involves monitoring the dynamics of the condition if the fibroids do not cause significant symptoms.<\/li>\n<li>Pharmacological treatments, including hormonal drugs (eg, progestogens and antiestrogens), ultrasound embolization, and medications that control the menstrual cycle.<\/li>\n<li>Surgical treatment such as myomectomy (removal of fibroids) or hysterectomy (removal of the uterus) if symptoms are severe or if you are planning to become pregnant.<\/li>\n<li>Other treatments, such as focused ultrasound or radiofrequency ablation, may be used to shrink fibroids.<\/li>\n<\/ul>\n<p>However, the choice of a specific treatment method depends on the individual characteristics of each patient and should be discussed with the attending physician.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%A1%D0%BF%D0%B8%D1%81%D0%BE%D0%BA_%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2_%D0%BF%D1%80%D0%B8%D0%BC%D0%B5%D0%BD%D1%8F%D0%B5%D0%BC%D1%8B%D1%85_%D0%B4%D0%BB%D1%8F_%D0%BB%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>List of medications used to treat this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>There are several classes of drugs that can be used to treat uterine fibroids:<\/p>\n<ul>\n<li>Hormonal contraceptives, such as combined oral contraceptives, which help regulate your menstrual cycle.<\/li>\n<li>Gonadotropin-releasing hormone (GnRH) agonists, such as leprolide, which may shrink fibroids.<\/li>\n<li>Progestogens, which help control menstrual bleeding.<\/li>\n<li>Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain relief.<\/li>\n<\/ul>\n<p>Each of these drugs has its own indications and contraindications, so their use should be carried out under the supervision of a physician.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%9C%D0%BE%D0%BD%D0%B8%D1%82%D0%BE%D1%80%D0%B8%D0%BD%D0%B3_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Disease monitoring<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Monitoring the condition of uterine fibroids involves regular check-ups to help track any changes in size or symptoms. Check-ups may include:<\/p>\n<ul>\n<li>Regular ultrasound to assess the dynamics of fibroid growth.<\/li>\n<li>Visits to the gynecologist to discuss symptoms and possible treatment adjustments.<\/li>\n<li>General monitoring of health status, especially in the presence of concomitant diseases.<\/li>\n<\/ul>\n<p>The prognosis for women with uterine fibroids is generally good. Most fibroids do not require surgical treatment, and symptoms respond well to drug therapy. However, it is important to remember that in rare cases, especially if the fibroid is rapidly increasing in size, complications such as anemia or infertility may occur.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%92%D0%BE%D0%B7%D1%80%D0%B0%D1%81%D1%82%D0%BD%D1%8B%D0%B5_%D0%BE%D1%81%D0%BE%D0%B1%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D0%B8_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Age-related features of the disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Uterine fibroids manifest differently depending on age group. In young women, in particular, fibroids may be asymptomatic and discovered incidentally during examinations. In women of reproductive age, fibroids often cause heavy menstrual bleeding and lower abdominal pain, which can negatively affect quality of life. In menopausal and postmenopausal patients, the risk of fibroid growth usually decreases, and many tumors may regress. However, in some cases, fibroids continue to exist and can cause complications requiring medical intervention.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%92%D0%BE%D0%BF%D1%80%D0%BE%D1%81%D1%8B_%D0%B8_%D0%BE%D1%82%D0%B2%D0%B5%D1%82%D1%8B\"><\/span>Questions and Answers<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>What is uterine fibroids?<\/strong> Uterine fibroids are benign tumors that develop in the muscular layer of the uterus and can cause pain and heavy menstrual bleeding.<\/li>\n<li><strong>What are the main symptoms of uterine fibroids?<\/strong> The main symptoms include heavy menstrual periods, pelvic pain, problems with urination and possible difficulty getting pregnant.<\/li>\n<li><strong>How is uterine fibroids diagnosed?<\/strong> The diagnosis is made based on clinical symptoms, ultrasound, MRI and other methods, including hysteroscopy.<\/li>\n<li><strong>What treatment is available for uterine fibroids?<\/strong> Treatment can be conservative with medication or surgical, depending on the size and symptoms of the fibroids.<\/li>\n<li><strong>What is the prognosis for women with uterine fibroids?<\/strong> In most cases, uterine fibroids have a favorable prognosis, and many women lead full lives.<\/li>\n<\/ul>\n<div class=\"fpm_end\"><\/div>","protected":false},"excerpt":{"rendered":"<p>Uterine fibroids, also known as fibroids or leiomyomas, are benign tumors that develop in the muscular layer of the uterus (myometrium). These tumors<\/p>","protected":false},"author":1,"featured_media":23991,"comment_status":"open","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[298],"tags":[],"class_list":["post-13350","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medlibrary"],"_links":{"self":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts\/13350","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/comments?post=13350"}],"version-history":[{"count":1,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts\/13350\/revisions"}],"predecessor-version":[{"id":13568,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts\/13350\/revisions\/13568"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/media\/23991"}],"wp:attachment":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/media?parent=13350"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/categories?post=13350"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/tags?post=13350"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}